文献速递肾移植

肾移植评估时的抑郁症状与进入肾移植等待名单的机会

Depressive Symptoms at Kidney Transplant Evaluation and Access to the Kidney Transplant Waitlist.
PubMed 文献 · Kidney Int Rep · 2022-03-15

该前瞻性队列纳入3728例肾移植评估患者,用CES-D量表评估抑郁症状。评估时85.8%患者至少存在轻微抑郁症状,年龄越大比例越低。校正临床和社会因素后,CES-D评分每高5分,1年内进入等待名单的机会降低13%(HR=0.87,95%CI:0.85-0.90),≥70岁者关联最强(aHR=0.73,95%CI:0.62-0.86)。

要点

  • 评估时85.8%的患者至少存在轻微抑郁症状,年龄越大报告比例越低。
  • 校正后CES-D评分每高5分,1年内进入等待名单的机会降低13%(HR=0.87)。
  • 即使轻微抑郁症状也与进入等待名单机会降低相关(HR=0.69)。

核心结论

  • 年龄较大的候选者在肾移植评估时报告抑郁症状的可能性较低;无论年龄,报告抑郁症状(即使轻微)的候选者进入等待名单的机会均较低。
  • 移植中心应常规筛查患者的抑郁症状,并将受影响的患者转介至心理健康服务,以改善肾移植的可及性。

研究设计与样本

  • 前瞻性队列研究,纳入3728例接受肾移植评估的患者,年龄18-88岁。
  • 使用流行病学研究中心抑郁量表(CES-D)在评估时测量抑郁症状。
  • 抑郁症状严重程度定义为:无=0分;轻微=1-15分;轻度=16-20分;中度=21-25分;重度=26-60分。
  • 采用Cox比例风险模型估计评估后1年内进入等待名单的风险比(HR),并校正临床和社会因素。

主要发现

  • 评估时85.8%的患者报告至少存在轻微抑郁症状;各年龄组比例:18-29岁=92.0%、30-39岁=88.3%、40-49岁=87.2%、50-59岁=87.0%、60-69岁=83.4%、≥70岁=82.0%。
  • 抑郁症状越严重,进入等待名单的机会越低(log-rank检验,P<0.001)。
  • 校正后,CES-D评分每高5分(抑郁症状更多),进入等待名单的机会降低13%(HR=0.87,95%CI:0.85-0.90)。
  • ≥70岁患者中关联最强(校正后HR=0.73,95%CI:0.62-0.86)。
  • 轻微(HR=0.69,95%CI:0.60-0.79)、轻度(HR=0.57,95%CI:0.44-0.72)、中度(HR=0.53,95%CI:0.39-0.71)、重度(HR=0.44,95%CI:0.34-0.57)抑郁症状均与进入等待名单的机会降低相关。

临床怎么用

  • 移植中心应常规筛查患者的抑郁症状,并将受影响的患者转介至心理健康服务,以改善肾移植的可及性(作者建议)。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

INTRODUCTION: Depressive symptoms, even without a clinical diagnosis of depression, are common in kidney failure patients and may be a barrier to completing the complex process of kidney transplant (KT) evaluation. We assessed depressive symptom burden and association between depressive symptoms and access to KT waitlist by age. METHODS: In a prospective cohort of 3728 KT patients (aged 18-88 years), the Center for Epidemiologic Studies-Depression (CES-D) scale was used to measure depressive symptoms at evaluation. Depressive symptom severity was defined as follows: none: 0; minimal: 1 to 15; mild: 16 to 20; moderate: 21 to 25; severe: 26 to 60. Hazard ratios (HRs) of active listing within 1 year after evaluation were estimated using Cox proportional hazards models, adjusted for clinical and social factors. RESULTS: At evaluation, 85.8% of the patients reported at least minimal depressive symptoms; the proportion was lower among older patients: 18 to 29 years = 92.0%; 30 to 39 years = 88.3%; 40 to 49 years = 87.2%; 50 to 59 years = 87.0%; 60 to 69 years = 83.4%; and ≥70 years = 82.0%. Chance of active listing decreased with more severe depressive symptoms (log-rank, P < 0.001). After adjustment, every 5-point higher CES-D score (more depressive symptoms) was associated with a 13% lower chance of listing (HR = 0.87, 95% CI: 0.85-0.90); the strongest association was found among patients aged ≥70 years (adjusted HR [aHR] = 0.73, 95% CI: 0.62-0.86). Furthermore, minimal (HR = 0.69, 95% CI: 0.60-0.79), mild (HR = 0.57, 95% CI: 0.44-0.72), moderate (HR = 0.53, 95% CI: 0.39-0.71), and severe (HR = 0.44, 95% CI: 0.34-0.57) depressive symptoms were all associated with a lower chance of listing. CONCLUSION: Older candidates were less likely to report depressive symptoms at KT evaluation. Regardless of age, candidates who did report depressive symptoms, and even minimal symptoms, had a lower chance of listing. Transplant centers should routinely screen patients for depressive symptoms and refer the affected patients to mental health services to improve access to KT.

来源:Kidney Int Rep,查看原文。版权归原作者所有。

引用

  1. Chen X, Chu NM, Basyal PS, et al. Depressive Symptoms at Kidney Transplant Evaluation and Access to the Kidney Transplant Waitlist. Kidney Int Rep. 2022. PMID: 35694557. doi:10.1016/j.ekir.2022.03.008

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。